Sunstein Insights
Back to All Publications
Strategic Implications for Pharmaceuticals in Recent U.S. Patent Law Developments
PPT download - Smi Pharmaceutical Portfolio and Product Life Cycle Management Conference, London, June 2010.
Most Popular
-
The Unified Patent Court and Unitary Patent Come to the European Patent Office
-
COHIBA v. COHIBA: TTAB orders cancellation of the COHIBA registration after a decades long dispute over the well-known trademark
-
Watch Me Pull a Customer Out of My Hat: Proving Damages Using Your Customer’s Out-Of-Court Statement
-
The FTC's Proposed Ban on Non-Compete Agreements: The Effect on Trade Secret Protection
-
Facebook Tracking Pixels are the basis for a new wave of privacy class action litigation
-
AI Machines Continue to Rattle Intellectual Property Law
-
Supreme Court to Hear the “Bad Spaniels” Case
Authors
-
Steven A. Abreu
-
Robert M. Asher
-
William Braunlin, Ph.D.
-
Thomas C. Carey
-
T.J. Clark
-
Lawrence M. Green
-
John T. Gutkoski
-
Bryan D. Harrison
-
Shane Hunter
-
Raïna S. Jacques
-
Peter J. Karol
-
Eric G. J. Kaviar
-
Christopher Lacenere, Ph.D.
-
Michele Liu Baillie
-
Sunstein
-
London K. Lundstrum
-
Ian Mahany-Horton
-
Odette T. Martins
-
Kevin R. Mosier
-
John W. Powell
-
Rob D. Pyatt
-
Francisco A. Rubio-Campos
-
Jackie Salwa
-
Andrew P. Siuta
-
Katherine W. Soule
-
Sharona H. Sternberg
-
Bruce D. Sunstein
-
Kerry L. Timbers
-
Lisa M. Tittemore
We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.